A Comparison of Sequential Compression Devices and Foot Pumps in the Obstetric Population
- Conditions
- Thrombophilia
- Interventions
- Device: Kendall sequential compression device, model 9525Device: Kendall A-V foot impulse pump, model 6060
- Registration Number
- NCT00356434
- Lead Sponsor
- Johns Hopkins University
- Brief Summary
The researchers at Johns Hopkins University believe that the foot pump will be superior to sequential compression devices in comfort and patient compliance which may increase provider efforts to prevent deep vein thrombosis (DVT) in pregnancy.
- Detailed Description
The investigators will be comparing sequential compression devices (SCDs) to foot pumps to determine if foot pumps will be better tolerated by obstetric patients, both antepartum and intrapartum. Patients in whom thromboembolic prophylaxis is deemed necessary and ordered by the treating physician, who agree to participate in the study will be randomly assigned to receive SCDs or the foot pump as part of their thromboembolic prophylaxis regimen. The investigators will administer a questionnaire to assess patients' satisfaction and comfort with each device and they will be asked to complete a log of hours they wore their assigned device for a 7 day period (or as long as they are prescribed). Random spot checks to verify compliance will be performed.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 11
- Pregnant
- Bedrest
- Thrombophilia
- Prescribed DVT prophylaxis
- Active DVT
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 2 Kendall sequential compression device, model 9525 Patients will have the Kendall,sequential compression device, model 9525 applied to the lower extremities to prevent DVT 1 Kendall A-V foot impulse pump, model 6060 Patients will have the Kendall, A-V foot impulse pump, model 6060 applied to their lower extremities to prevent DVT
- Primary Outcome Measures
Name Time Method Patient Compliance for 1-7 days during hospitalization Nurse conducting random checks throughout hospital stay and events of noncompliance will be recorded
Comfort Level once during first 7 days of hospitalization Scale of 1-10 (1 being very uncomfortable and 10 being very uncomfortable) describing level of comfort during the time of device use (composite score of heat, softness, discomfort).
- Secondary Outcome Measures
Name Time Method DVT Prevention up to 3 months positive DVT on ultrasound
Trial Locations
- Locations (2)
Johns Hopkins Hospital
🇺🇸Baltimore, Maryland, United States
Johns Hopkins Bayview Medical Center
🇺🇸Baltimore, Maryland, United States